Feedback on Evolving Patient Group Input Submissions into the Drug Reimbursement Review Process
ALS Action Canada Submission to the Canada Drug Agency 1.1 What suggestions do you have for evolving the patient input process to focus on what is needed to support deliberations on the deliberative framework domains? The Advocacy Committee of ALS Action Canada (ALSAC) very much appreciates the extensive efforts being made by CDA’s Engagement Group […]